OGN
Income statement / Annual
Last year (2023), Organon & Co.'s total revenue was $6.26 B,
an increase of 1.44% from the previous year.
In 2023, Organon & Co.'s net income was $1.02 B.
See Organon & Co.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$6.26 B
|
$6.17 B
|
$6.30 B
|
$8.10 B
|
$7.78 B
|
$9.78 B
|
$10.50 B
|
| Cost of Revenue |
$2.52 B |
$2.29 B |
$2.38 B |
$3.35 B |
$2.27 B |
$4.69 B |
$4.59 B |
| Gross Profit |
$3.75 B |
$3.88 B |
$3.92 B |
$4.75 B |
$5.50 B |
$5.08 B |
$5.91 B |
| Gross Profit Ratio |
0.6 |
0.63 |
0.62 |
0.59 |
0.71 |
0.52 |
0.56 |
| Research and Development
Expenses |
$536.00 M
|
$471.00 M
|
$443.00 M
|
$304.00 M
|
$220.00 M
|
$365.00 M
|
$355.00 M
|
| General & Administrative
Expenses |
$1.68 B
|
$1.45 B
|
$1.43 B
|
$1.47 B
|
$1.18 B
|
$1.69 B
|
$1.93 B
|
| Selling & Marketing
Expenses |
$209.00 M
|
$255.00 M
|
$236.00 M
|
$198.00 M
|
$262.00 M
|
$322.00 M
|
$356.00 M
|
| Selling, General &
Administrative Expenses |
$1.89 B
|
$1.70 B
|
$1.67 B
|
$1.67 B
|
$1.44 B
|
$2.01 B
|
$2.29 B
|
| Other Expenses |
-$15.00 M |
-$15.00 M |
-$279.00 M |
-$29.00 M |
$7.00 M |
$142.00 M |
$0.00 |
| Operating Expenses |
$2.43 B |
$2.18 B |
$2.11 B |
$1.97 B |
$1.66 B |
$2.38 B |
$2.64 B |
| Cost And Expenses |
$4.94 B |
$4.47 B |
$4.49 B |
$5.32 B |
$3.94 B |
$7.07 B |
$7.23 B |
| Interest Income |
$0.00 |
$422.00 M |
$258.00 M |
$0.00 |
$19.00 M |
$0.00 |
$11.00 M |
| Interest Expense |
$527.00 M |
$422.00 M |
$258.00 M |
$6.00 M |
$6.00 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$236.00 M
|
$212.00 M
|
$195.00 M
|
$142.00 M
|
$354.00 M
|
$1.67 B
|
$1.97 B
|
| EBITDA |
$1.55 B
|
$1.69 B
|
$1.81 B
|
$3.01 B
|
$4.18 B
|
$4.50 B
|
$5.25 B
|
| EBITDA Ratio |
0.25 |
0.27 |
0.29 |
0.37 |
0.54 |
0.46 |
0.5 |
| Operating Income Ratio
|
0.21
|
0.24
|
0.26
|
0.35
|
0.49
|
0.28
|
0.31
|
| Total Other
Income/Expenses Net |
-$646.00 M
|
-$356.00 M
|
-$90.00 M
|
-$169.00 M
|
-$151.00 M
|
$23.00 M
|
-$173.00 M
|
| Income Before Tax |
$673.00 M |
$1.12 B |
$1.53 B |
$2.68 B |
$3.70 B |
$2.73 B |
$3.10 B |
| Income Before Tax Ratio
|
0.11
|
0.18
|
0.24
|
0.33
|
0.48
|
0.28
|
0.3
|
| Income Tax Expense |
-$350.00 M |
$205.00 M |
$178.00 M |
$520.00 M |
$390.00 M |
$576.00 M |
$1.30 B |
| Net Income |
$1.02 B |
$917.00 M |
$1.35 B |
$2.16 B |
$3.22 B |
$2.15 B |
$1.80 B |
| Net Income Ratio |
0.16 |
0.15 |
0.21 |
0.27 |
0.41 |
0.22 |
0.17 |
| EPS |
4.01 |
3.61 |
5.33 |
8.52 |
12.71 |
8.51 |
7.11 |
| EPS Diluted |
3.99 |
3.59 |
5.33 |
8.52 |
12.71 |
8.51 |
7.11 |
| Weighted Average Shares
Out |
$255.24 M
|
$254.08 M
|
$253.55 M
|
$253.52 M
|
$253.13 M
|
$253.13 M
|
$253.13 M
|
| Weighted Average Shares
Out Diluted |
$256.27 M
|
$255.17 M
|
$253.55 M
|
$253.52 M
|
$253.13 M
|
$253.13 M
|
$253.13 M
|
| Link |
|
|
|
|
|
|
|
